Orexin-1 and orexin-2 receptor antagonists reduce ethanol self-administration in high-drinking rodent models

Rachel I Anderson1, Howard C Becker2, Benjamin L Adams3

  • 1Medical University of South Carolina Charleston, SC, USA ; Charleston Alcohol Research Center Charleston, SC, USA.

Insights

Orexin receptor antagonists reduced ethanol intake in rodent models, but effects may not be specific to alcohol consumption. Further research is needed to understand the role of orexin receptor activity in ethanol self-administration.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Addiction Research

Background:

  • The orexin system plays a role in regulating arousal, reward, and motivated behaviors, including substance use.
  • Orexin receptor subtypes (OX1 and OX2) are potential targets for treating alcohol use disorder.

Purpose of the Study:

  • To investigate the specific roles of orexin-1 (OX1) and orexin-2 (OX2) receptor activity in ethanol self-administration.
  • To assess the effects of selective and mixed orexin receptor antagonists on ethanol consumption in rodent models.

Main Methods:

  • Utilized high-drinking rodent models (ethanol-preferring rats and C57BL/6J mice).
  • Administered OX1 antagonist (SB334867), OX2 antagonist (LSN2424100), and mixed OX1/2 antagonist (almorexant) in various self-administration paradigms.
  • Assessed effects on home cage ethanol consumption, operant ethanol self-administration under progressive ratio, and binge-like drinking (drinking-in-the-dark).

Main Results:

  • SB334867 and almorexant reduced home cage ethanol intake in rats, though almorexant also affected water intake.
  • LSN2424100 and almorexant decreased motivation for ethanol in operant tasks, while SB334867 had no significant effect.
  • All tested orexin antagonists reduced ethanol intake and blood ethanol levels in mice, but also non-selectively reduced sucrose intake, indicating potential off-target effects.

Conclusions:

  • Orexin receptor activity, involving both OX1 and OX2, influences ethanol self-administration.
  • The observed effects of orexin antagonists on ethanol consumption may not be entirely selective, suggesting broader impacts on motivated behaviors or consummatory processes.
  • Further investigation is warranted to delineate the specific contributions of OX1 and OX2 receptors to alcohol-related behaviors and to develop selective therapeutic strategies.